Casdin Capital’s CareDx CDNA Stock Holding History

Casdin Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,153,335	Closed	-$42.7M	–	42
2022 Q1	$42.7M	Hold	1,153,335	–	–	1.91%	21
2021 Q4	$52.5M	Sell	1,153,335 -40,000	-3%	-$2.09M	1.48%	23
2021 Q3	$75.6M	Hold	1,193,335	–	–	1.88%	21
2021 Q2	$109M	Hold	1,193,335	–	–	2.77%	13
2021 Q1	$81.3M	Hold	1,193,335	–	–	2.42%	15
2020 Q4	$86.5M	Hold	1,193,335	–	–	2.56%	14
2020 Q3	$45.3M	Hold	1,193,335	–	–	2.03%	17
2020 Q2	$42.3M	Sell	1,193,335 -101,000	-8%	-$2.87M	2.5%	13
2020 Q1	$28.3M	Buy	1,294,335 +94,335	+8%	+$2.11M	3%	13
2019 Q4	$25.9M	Buy	1,200,000 +200,000	+20%	+$4.59M	2.38%	14
2019 Q3	$22.6M	Buy	1,000,000 +800,000	+400%	+$22.2M	2.34%	15
2019 Q2	$7.2M	Hold	200,000	–	–	0.67%	28
2019 Q1	$6.3M	Hold	200,000	–	–	0.69%	26
2018 Q4	$5.03M	Hold	200,000	–	–	0.86%	28
2018 Q3	$5.77M	Hold	200,000	–	–	0.7%	30
2018 Q2	$2.45M	Buy	+200,000	New	+$2.29M	0.34%	32

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Casdin Capital's CDNA Position: Q2 2022 in Review

Casdin Capital sold out of CareDx (CDNA) in Q2 2022, closing a stake of 1,153,335 shares — an estimated $42.7M sold.

Casdin Capital first reported a position in CDNA in Q2 2018 and held it in 16 quarters. The position peaked at $109M in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

Casdin Capital reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
Casdin Capital sold 1,153,335 CareDx shares in Q2 2022, an estimated $42.7M.
Casdin Capital first reported a position in CareDx in Q2 2018 and held it in 16 quarters.
Casdin Capital's CareDx position peaked at $109M in Q2 2021.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Casdin Capital's 13F filing for Q2 2022, filed 15 Aug 2022.